Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life Setting-Reference-Cited by-同舟云学术

Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life Setting

Published:2021-06-01 Issue:6 Volume:37 Page:478-485
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Di Carlo Daniele¹,Falasca Francesca¹,Palermo Enrico²,Mezzaroma Ivano³,Fimiani Caterina⁴,Siccardi Guido⁵,Celani Luigi⁵,Di Campli Francesco Maria⁵,d'Ettorre Gabriella⁵,Antonelli Guido¹,Turriziani Ombretta¹

Affiliation:

1. Department of Molecular Medicine, University of Rome Sapienza, Rome, Italy.

2. Istituto Pasteur-Fondazione Cenci Bolognetti, Rome, Italy.

3. Department of Translational and Precision Medicine, University of Rome Sapienza, Rome, Italy.

4. Department of Infectious Diseases, Umberto I University Hospital, Rome, Italy.

5. Department of Public Health and Infectious Diseases, University of Rome Sapienza, Rome, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2020.0196

Reference39 articles.

1. Latent reservoirs of HIV: Obstacles to the eradication of virus

2. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

3. Ageing and inflammation in patients with HIV infection

4. What happens to cardiovascular system behind the undetectable level of HIV viremia?

5. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus–Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus–Uninfected Controls

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and predictors of persistent low-level HIV viraemia: a retrospective cohort study among people receiving dolutegravir-based antiretroviral therapy in Southern Nigeria;Therapeutic Advances in Infectious Disease;2024-01

2. Optimizing antiretroviral therapy for children living with HIV: Experience from an observational cohort in Lesotho;PLOS ONE;2023-07-17

3. HIV VIRAL SUPPRESSION AND ASSOCIATED FACTORS AMONG CHILDREN AND ADOLESCENTS ON A DOLUTEGRAVIR (DTG) BASED ANTIRETROVIRAL REGIMEN IN TANZANIA MAINLAND;2023-05-25

4. Effectiveness and Safety Analysis of PIs/r Based Dual Therapy in Treatment-Naïve, HIV/AIDS Patients: A Network Meta Analysis of Randomized Controlled Trials;Frontiers in Pharmacology;2022-03-04

5. Predictors of Viral Non-Suppression among Patients Living with HIV under Dolutegravir in Bunia, Democratic Republic of Congo: A Prospective Cohort Study;International Journal of Environmental Research and Public Health;2022-01-19